Impact on Quality of Life and Burden of Disease in Adults With Herpes Zoster
NCT06667245 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 357
Last updated 2024-10-31
Summary
Title: Impact on quality of life and disease burden in adults with herpes zoster
Prospective cohort study for the primary objective and the secondary objectives (1 and 2) and retrospective cohort study for the secondary objective 3.
Disease or disorder under study: Patients with a herpes zoster (HZ) diagnosis.
Conditions
- Herpes Zoster
- Quality of Life
- Immunization; Infection
Sponsors & Collaborators
-
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-04
- Primary Completion
- 2025-11-04
- Completion
- 2026-11-04
Countries
- Spain
Study Locations
More Related Trials
-
Shingles Prevention Study
NCT00007501 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells
NCT02090803 ·Status: COMPLETED
-
The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy Setting
NCT00689013 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of SYS6017 in Healthy Participants Aged 40 Years or More
NCT06954818 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Assess the Burden of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged Sixty Years and Above
NCT01873365 ·Status: COMPLETED
-
A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes
NCT05298254 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Treating Genital Herpes Infection to Reduce Racial Disparities in the Risk of Severe Maternal Morbidity
NCT05429346 ·Status: RECRUITING
-
Efficacy of Oral Famciclovir Versus Aciclovir Treatment in Patients With Herpes Zoster
NCT01327144 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes Zoster
NCT02151240 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection
NCT01915212 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Characteristics of Patients Diagnosed With Recurrent Symptomatic Genital Herpetic Disease
NCT05500053 ·Status: COMPLETED
-
An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.
NCT04950712 ·Status: COMPLETED
-
Immune Response and General Immune Health in Subjects Infected With Herpes Simplex Virus Type 1 (HSV-1)
NCT03661541 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
NCT01165203 ·Status: COMPLETED ·Phase: PHASE2
-
An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies
NCT00002272 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of 4 Investigational HSV 2 Vaccines in Adults With Recurrent Genital Herpes Caused by HSV 2
NCT04222985 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluating New Formulation of Therapeutic HSV-2 Vaccine
NCT02515175 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster
NCT05492591 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Over
NCT06569823 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant
NCT00697567 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes
NCT06033261 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster
NCT01827839 ·Status: COMPLETED ·Phase: PHASE3
-
Non-inferiority Study of ZK-A03 in Treatment of Herpes Zoster Before and After the Alteration of the Active Ingredient Manufacturer
NCT05806918 ·Status: UNKNOWN ·Phase: PHASE3
-
Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected Patients
NCT00127608 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Systems
NCT00002315 ·Status: COMPLETED ·Phase: PHASE3